Sana Biotechnology, Inc.

NASDAQ:SANA

1.76 (USD) • At close April 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -49.069-59.924-50.291-107.475-88.1170.984-113.999-82.123-80.443-85.12-72.465-31.448-110.731-83.26318.683-180.617-113.17-51.452-87.808-32.875-43.045
Depreciation & Amortization 5.6934.0573.8953.7467.5414.4994.4484.3464.1954.0163.83.6143.3352.8822.6062.2471.7551.521.3811.2651.028
Deferred Income Tax 0000-24.34900000000000-7.547000-1.343
Stock Based Compensation 6.43610.7711.389.0927.9319.0039.8488.75110.59110.089.9117.7557.3135.954.9414.1582.7911.1661.1160.7550.487
Change In Working Capital 4.271-0.3442.349-7.46110.2445.17713.997-10.807-5.58812.0744.417-3.361-1.5375.6668.808-3.1362.6645.342-0.737-1.1134.634
Accounts Receivables 000000000000000000000
Change In Inventory 000000000000000000000
Change In Accounts Payables 2.281-0.5070.667-1.064-1.3362.2760.441-0.354-1.0861.481-1.2541.917-1.6631.77-1.9721.599-0.4320.55-0.5062.37-0.89
Other Working Capital 1.990.1631.682-6.39711.582.90113.556-10.453-4.50210.5935.671-5.2780.1263.89610.78-4.7353.0964.792-0.231-3.4835.524
Other Non Cash Items -14.492-6.378-7.37154.11434.791-83.21326.9050.561-4.822-5.846-17.141-54.269-8.47918.279-75.594127.43575.9485.91452.6822.4214.443
Operating Cash Flow -47.161-51.819-58.541-65.632-51.959-63.55-58.801-79.272-76.067-64.796-71.478-77.709-110.099-50.486-40.556-49.913-37.559-37.51-33.366-29.547-33.796
Investing Activities:
Investments In Property Plant And Equipment -0.436-4.093-13.056-15.845-14.046-2.233-1.577-2.176-4.602-4.35-4.391-7.533-5.202-8.064-10.156-6.44-9.266-6.316-2.69-5.6-5.73
Acquisitions Net 0000-0.029-0.054-0.04400-0.036-0.08200000-3.1950000
Purchases Of Investments -13.076-35.97-62.625-114.393-26.127-60.35-50.836-20.431-15.105-17.622-20.286-25.675-76.95-248.886-120.74-44.811-80.034-264.277-43.1210-11.124
Sales Maturities Of Investments 60.681.83881.49953.0155.483113.93195.0485.334108.13553.831102.40745.75313.06571.04695.572100.342102.3412.289.33944.78143.637
Other Investing Activites 000-61.3830.0290.0540.044000.0360.08220.078-4.574-177.84-25.16855.5313.195-261.997-33.78244.78132.513
Investing Cash Flow 47.08841.7755.818-77.22815.3151.34842.62762.72788.42831.85977.7312.545-73.661-185.904-35.32449.09113.041-268.313-36.47239.18126.783
Financing Activities:
Debt Repayment 000000000000000000000
Common Stock Issued 0-0.029-0.439181.4681.718-0.00527.0140-0.1231.6211.5790.6523.1191.5960.333626.4050.1030.046000
Common Stock Repurchased 000000000000000000000
Dividends Paid 000000000000000000000
Other Financing Activities 0.6432.11111.0664.92900.1922.4910.2361.1840003.1191.5960.3330.29800.004435.5780.0027.815
Financing Cash Flow 0.6432.08210.627186.3971.7180.18729.5050.2361.0611.6211.5790.6523.1191.5960.333626.7030.1030.004435.5780.0027.815
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000
Net Change In Cash 0.57-7.962-42.09643.537-34.931-12.01513.331-16.30913.422-31.3167.831-64.512-180.641-234.794-75.547625.881-24.415-305.819365.749.6360.802
Cash At End Of Period 131.398130.828138.79180.886137.349172.28184.295170.964187.273173.851205.167197.336261.848442.489677.283752.83126.949151.364457.18391.44381.807